日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study

一项针对≥60岁FLT3突变型急性髓系白血病(AML)成人患者的FILO-DATAML-PETHEMA真实世界研究:强化化疗联合或不联合米哚妥林治疗的疗效评价

Aspas Requena, Gaspar; Montesinos, Pau; Bérard, Emilie; Bertoli, Sarah; Rodríguez-Veiga, Rebeca; Simand, Celestine; Torres, Laura; Peterlin, Pierre; Tormo, Mar; Birsen, Rudy; Bergua-Burgues, Juan Miguel; Tavernier, Emmanuelle; Bernal Del Castillo, Teresa; Carré, Martin; Gil, Cristina; Contejean, Adrien; Rodríguez-Arbolí, Eduardo; Orvain, Corentin; Rodríguez-Medina, Carlos; Veronese, Lauren; Sayas Lloris, Maria Jose; Delabesse, Eric; Serrano, Josefina; Mineur, Ariane; García-Fortes, María; Guieze, Romain; Amigo, Maria Luz; Pigneux, Arnaud; Algarra Algarra, Lorenzo; Recher, Christian; Dumas, Pierre-Yves; Martínez-Cuadrón, David

Pediatric in-hospital life-threatening emergencies and cardiac arrest in France: adherence to international guidelines and barriers to implementation

法国儿科院内危及生命的紧急情况和心脏骤停:国际指南的遵循情况及实施障碍

Lockhart-Bouron, Marguerite; Exbrayat, Johann; Baert, Valentine; Hubert, Hervé; Recher, Morgan; Leteurtre, Stéphane

Evaluation of the Analgesia Nociception Index (ANI) as an indicator of discomfort in deeply sedated, prepubescent patients

评估镇痛伤害感受指数 (ANI) 作为深度镇静的青春期前患者不适感指标的价值

Barat, Alexis; Wojtanowski, Anne; Behal, Hélène; Flocteil, Mathilde; Leteurtre, Stéphane; De Jonckheere, Julien; Recher, Morgan

HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation

异基因造血干细胞移植后供体淋巴细胞输注后的HLA进化差异评分

Le Grand, Sophie; Villemonteix, Juliette; Daguindau, Etienne; Fort, Marylise; Caillat-Zucman, Sophie; Allain, Vincent; Dormoy, Anne; De Mas, Veronique; Delabesse, Eric; Recher, Christian; Peffault de Latour, Regis; Vallet, Nicolas; Michonneau, David; Guenounou, Sarah; Huynh, Anne

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML

长期随访及eprenetapopt联合阿扎胞苷治疗TP53突变型MDS/AML患者的II期联合试验结果

Sallman, David A; Komrokji, Rami S; Dezern, Amy E; Sebert, Marie; Garcia-Manero, Guillermo; Rahmé, Ramy; Winer, Eric S; Lehmann-Che, Jacqueline; Roboz, Gail J; Madelaine, Isabelle; Sekeres, Mikkael A; Peterlin, Pierre; Chan, Onyee; Beyne-Rauzy, Odile; Kuykendall, Andrew; Recher, Christian; McLemore, Amy; Stamatoullas, Aspasia; Zhang, Ling; Willems, Lise; Mo, Qianxing; Raffoux, Emmanuel; Nardelli, Lisa; Berthon, Céline; Al Ali, Najla H; Quesnel, Bruno; Padron, Eric; Kantarjian, Hagop M; List, Alan F; Ades, Lionel; Lancet, Jeffrey E; Fenaux, Pierre; Cluzeau, Thomas

Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

维奈托克和阿扎胞苷用于未经治疗的治疗相关性急性髓系白血病、既往骨髓增生异常综合征或慢性粒单核细胞白血病患者

Pullarkat, Vinod; Pratz, Keith W; Döhner, Hartmut; Recher, Christian; Thirman, Michael J; DiNardo, Courtney D; Fenaux, Pierre; Schuh, Andre C; Wei, Andrew H; Pigneux, Arnaud; Jang, Jun-Ho; Juliusson, Gunnar; Miyazaki, Yasushi; Selleslag, Dominik; Arellano, Martha L; Liu, Chenglong; Ridgeway, Jean A; Potluri, Jalaja; Schuler, Jovita; Konopleva, Marina

Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS

CPX-351治疗高危急性髓系白血病(AML)患者的长期真实世界证据表明,该疗法可显著提高微小残留病灶(MRD)阴性率并延长总生存期(OS)。

Cluzeau, Thomas; Guolo, Fabio; Chiche, Edmond; Minetto, Paola; Rahme, Ramy; Bertoli, Sarah; Fianchi, Luana; Micol, Jean-Baptiste; Gottardi, Michele; Peterlin, Pierre; Galimberti, Sara; Thomas, Xavier; Rizzuto, Giuliana; Legrand, Olivier; Rondoni, Michela; Raffoux, Emmanuel; Bertani, Giambattista; Caulier, Alexis; D'Argenio, Michelina; Bonmati, Caroline; Billio, Atto; Lejeune, Caroline; Scappini, Barbara; Pigneux, Arnaud; Zappasodi, Patrizia; Recher, Christan; Grimaldi, Francesco; Ades, Lionel; Lemoli, Roberto M

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML

AGILE 研究评估了阿扎胞苷联合 ivosidenib 与安慰剂治疗新诊断的 IDH1 突变型 AML 的长期疗效。

Montesinos, Pau; Marchione, Dylan M; Recher, Christian; Heuser, Michael; Vives, Susana; Zarzycka, Ewa; Wang, Jianxiang; Riva, Marta; Calado, Rodrigo T; Schuh, Andre C; Yeh, Su-Peng; Tron, Adriana E; Hui, Jianan; Gianolio, Diego A; Choe, Sung; Patel, Prapti; De Botton, Stéphane; DiNardo, Courtney D; Döhner, Hartmut

Recognition of MR1-antigen complexes by TCR Vγ9Vδ2

TCR Vγ9Vδ2 对 MR1 抗原复合物的识别

José Pedro Loureiro,Alessandro Vacchini,Giuliano Berloffa,Jan Devan,Verena Schaefer,Vladimir Nosi,Rodrigo Colombo,Aisha Beshirova,Giulia Montanelli,Benedikt Meyer,Timothy Sharpe,Andrew Chancellor,Mike Recher,Lucia Mori,Gennaro De Libero

Self-Efficacy Effects on Symptom Experiences in Daily Life and Early Treatment Success in Anxiety Patients

自我效能感对焦虑症患者日常生活症状体验和早期治疗成功的影响

Paersch, Christina; Recher, Dominique; Schulz, Ava; Henninger, Mirka; Schlup, Barbara; Künzler, Florian; Homan, Stephanie; Kowatsch, Tobias; Fisher, Aaron J; Horn, Andrea B; Kleim, Birgit